当前位置:首页 - 行情中心 - 启迪药业(000590) - 财务分析 - 资产负债表

启迪药业

(000590)

  

流通市值:14.12亿  总市值:14.13亿
流通股本:2.39亿   总股本:2.39亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金189,769,846.04156,222,549.75200,371,041.24184,927,238.02
应收票据及应收账款81,860,636.3543,398,242.9745,279,407.8662,146,518.97
其中:应收票据60,312,490.228,647,412.3429,487,271.4943,279,409.96
应收账款21,548,146.1514,750,830.6315,792,136.3718,867,109.01
应收款项融资70,392,273.8466,156,819.9679,912,406.6686,750,573.95
预付款项4,680,211.772,532,426.282,158,346.333,412,757.11
其他应收款合计60,511,490.0435,237,968.8433,747,929.6231,628,260.4
存货130,086,662.21122,462,394.19126,095,790.06133,364,483.7
一年内到期的非流动资产2,145,621.672,080,956.944,490,503.892,399,944.05
其他流动资产105,201.33298,246.332,229,943.27780,847.92
流动资产平衡项目0000
流动资产合计539,551,943.25483,389,605.26494,285,368.93525,508,957.45
非流动资产:
长期应收款5,054,263.985,887,067.014,112,310.056,854,621.05
其他非流动金融资产20,900,00019,000,00019,000,00019,000,000
投资性房地产18,661,173.3516,568,572.3216,762,122.5116,955,672.7
固定资产264,685,128.32258,818,505.17262,953,885.46262,809,746.73
在建工程23,834,157.2130,195,414.0920,548,238.3720,652,084.93
使用权资产5,291,894.525,730,788.546,655,410.747,353,245.81
无形资产132,326,601.37153,062,842.37154,623,275.96155,885,816.63
商誉131,644,827.76137,143,972.34137,143,972.34137,143,972.34
长期待摊费用3,323,306.012,194,614.622,458,918.082,780,695.8
递延所得税资产4,088,885.484,302,161.064,505,569.084,749,620.74
其他非流动资产1,758,720.411,150,3801,150,3801,170,180
非流动资产平衡项目0000
非流动资产合计611,568,958.41634,054,317.52629,914,082.59635,355,656.73
资产平衡项目0000
资产总计1,151,120,901.661,117,443,922.781,124,199,451.521,160,864,614.18
流动负债:
短期借款-5,000,00010,000,00035,000,000
应付票据及应付账款83,552,876.3570,619,016.1363,827,460.1673,014,650.32
其中:应付票据35,964,675.8731,958,963.4121,593,071.4111,891,037.9
应付账款47,588,200.4838,660,052.7242,234,388.7561,123,612.42
合同负债50,121,780.0355,111,354.3559,042,501.7156,696,862.33
应付职工薪酬40,100,682.7417,793,757.9817,189,354.0916,750,447.86
应交税费9,448,615.465,835,718.255,532,202.615,148,474.02
其他应付款合计47,154,090.8546,437,533.6948,899,117.4649,295,039.65
一年内到期的非流动负债12,359,162.646,288,351.776,539,163.5612,610,022.7
其他流动负债6,032,942.228,655,623.8210,820,867.919,615,618.34
流动负债平衡项目0000
流动负债合计248,770,150.29215,741,355.99221,850,667.5258,131,115.22
非流动负债:
长期借款80,000,00090,000,00090,000,00090,000,000
租赁负债3,070,298.755,114,677.65,389,773.235,442,881.88
长期应付职工薪酬42,203,361.4647,486,407.0947,299,511.9546,587,648.91
递延收益42,442,541.1242,923,349.5643,404,15843,884,966.44
递延所得税负债5,914,453.716,728,156.346,878,932.597,056,698.57
其他非流动负债517,091.45562,354.49609,030.54658,921.34
非流动负债平衡项目0000
非流动负债合计174,147,746.49192,814,945.08193,581,406.31193,631,117.14
负债平衡项目0000
负债合计422,917,896.78408,556,301.07415,432,073.81451,762,232.36
所有者权益(或股东权益):
实收资本(或股本)239,471,267239,471,267239,471,267239,471,267
资本公积474,064,292.56474,064,292.56474,064,292.56474,064,292.56
盈余公积45,898,527.3645,898,527.3645,898,527.3645,898,527.36
未分配利润-35,716,444.62-54,535,517.16-54,583,126.1-54,380,866.55
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计723,717,642.3704,898,569.76704,850,960.82705,053,220.37
少数股东权益4,485,362.583,989,051.953,916,416.894,049,161.45
股东权益平衡项目0000
股东权益合计728,203,004.88708,887,621.71708,767,377.71709,102,381.82
负债和股东权益合计1,151,120,901.661,117,443,922.781,124,199,451.521,160,864,614.18
公告日期2024-03-282023-10-282023-08-232023-04-26
审计意见(境内)标准无保留意见
TOP↑